Jardiance (empagliflozin) is not approved for weight loss. It’s a diabetes and heart failure medication that happens to cause modest weight loss as a side effect, typically around 2.5% to 3.2% of body weight over 24 weeks. That’s roughly 4 to 5 pounds for someone who weighs 175 pounds. While some doctors prescribe it off-label with weight management in mind, it’s far from a dedicated weight loss drug.
What Jardiance Is Actually Approved For
The FDA has approved Jardiance for four specific uses: improving blood sugar control in adults and children (10 and older) with type 2 diabetes, reducing cardiovascular death risk in adults with type 2 diabetes and established heart disease, reducing hospitalizations and cardiovascular death in adults with heart failure, and slowing kidney disease progression. Weight loss is not among them.
Any weight loss that occurs while taking Jardiance is considered a secondary benefit, not the drug’s purpose. This matters because insurance coverage, prescribing decisions, and dosing are all built around these approved uses, not weight management.
How Jardiance Causes Weight Loss
Jardiance works by blocking a protein in your kidneys that normally reabsorbs sugar back into your bloodstream. With that protein blocked, your kidneys filter out excess glucose, and you excrete it in your urine. This means calories that would otherwise be absorbed leave your body instead.
That calorie loss is the primary driver of weight reduction, but it’s not the whole story. Research shows the drug also shifts your body’s fuel source. When less glucose is available for energy, your body compensates by burning more fat. Animal studies published in BMJ Open Diabetes Research & Care found that empagliflozin increased overall energy expenditure and promoted a process called “fat browning,” where stored white fat converts into a more metabolically active form that burns calories. The drug also appeared to reduce inflammation in fat tissue, which is linked to improved metabolic health.
There’s also an initial water weight component. Because the drug increases urination (sugar pulls water along with it), some of the early weight drop is fluid loss rather than fat. Over time, though, the sustained calorie deficit from glucose excretion contributes to actual fat reduction.
How Much Weight People Actually Lose
Clinical trial data puts the weight loss in perspective. In a pooled analysis of four 24-week studies involving 2,476 adults with type 2 diabetes, people taking Jardiance lost about 1.9 kilograms (roughly 4.2 pounds) more than those on a placebo. A shorter 12-week study of 823 adults showed a 1.7-kilogram (3.7-pound) difference.
In percentage terms, the 10 mg dose produced about 2.5% to 2.8% body weight loss, while the 25 mg dose produced about 2.8% to 3.2%, compared to just 0.4% in the placebo group. The difference between the two doses is small, and neither produces the kind of dramatic results people see with newer GLP-1 medications like semaglutide, which can produce 10% to 15% body weight reduction.
How Long It Takes to See Results
Blood sugar effects can appear relatively quickly, but weight loss builds gradually. Clinical studies measured their primary weight outcomes at 24 weeks, and that’s the general timeline for seeing the full effect. Some people notice changes earlier, particularly in the first few weeks when fluid loss contributes to the number on the scale. The fat-related portion of weight loss accumulates more slowly as the ongoing calorie deficit from glucose excretion adds up over months.
Common Side Effects
The mechanism that drives weight loss, excreting sugar through urine, also creates the drug’s most common side effects. Sugar in the urinary tract creates a favorable environment for infections, so urinary tract infections and genital yeast infections (particularly in women) are the most frequently reported problems. In some cases, urinary tract infections can become serious enough to require hospitalization.
Because the drug increases urination, dehydration is another concern. This can cause dizziness, lightheadedness, or feeling faint when standing up, especially in the early weeks or during hot weather. Staying well-hydrated helps, but people who are already on blood pressure medications or diuretics face a higher risk.
How Jardiance Compares to Weight Loss Medications
If your primary goal is losing weight, Jardiance is not the most effective option available. The newer GLP-1 receptor agonists work by suppressing appetite and slowing digestion, producing significantly greater weight loss. Jardiance’s 3% to 4% body weight reduction over six months is meaningful for metabolic health, particularly for people with diabetes, but it won’t produce the transformative results many people are looking for when they search for weight loss solutions.
Where Jardiance has a distinct advantage is in its additional benefits for the heart and kidneys. For someone with type 2 diabetes who also has cardiovascular risk factors or early kidney disease, the modest weight loss is a welcome bonus on top of the drug’s primary protective effects. The weight loss mechanism is also fundamentally different from appetite-based drugs: you don’t need to eat less or feel less hungry for it to work, since the calorie loss happens through your kidneys regardless of your diet.